Biogen (BIIB) Long-Term Deferred Tax (2017 - 2026)
Biogen (BIIB) reported Long-Term Deferred Tax of $202.1 million for Q2 2026, down 38.9% from $330.9 million a year earlier and down 15.2% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Long-Term Deferred Tax (2017 - 2026) Analysis & Trends
At the end of FY2025, Biogen posted Long-Term Deferred Tax of $292.5 million, down 9.8% from FY2024.
- Long-Term Deferred Tax has declined for four consecutive years, with a five-year compound annual growth rate of -26.6% (FY2020 to FY2025).
- By year, Long-Term Deferred Tax came in at $324.2 million in FY2024 (-65.1%), $928.6 million in FY2023 (-24.3%), $1.23 billion in FY2022 (-13.3%) and $1.42 billion in FY2021 (+3.3%).
- The Q2 2026 figure ranks as the lowest quarterly Long-Term Deferred Tax in data going back to Q4 2017.
- Year over year, Long-Term Deferred Tax has now declined in each of the last 17 quarters, with an average decline of 42.9% over the last eight quarters.
- The high point for year-over-year Long-Term Deferred Tax in five years was Q3 2021 (growth of 31.9%); the low point was Q3 2025 (a decline of 67.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $238.2 million (Q1 2026), $292.5 million (Q4 2025) and $312.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 202.10 Mn |
| Mar 31, 2026 | 238.20 Mn |
| Dec 31, 2025 | 292.50 Mn |
| Sep 30, 2025 | 312.40 Mn |
| Jun 30, 2025 | 330.90 Mn |
| Mar 31, 2025 | 307.50 Mn |
| Dec 31, 2024 | 324.20 Mn |
| Sep 30, 2024 | 968.70 Mn |
| Jun 30, 2024 | 915.10 Mn |
| Mar 31, 2024 | 898.30 Mn |
| Dec 31, 2023 | 928.60 Mn |
| Sep 30, 2023 | 1.07 Bn |
| Jun 30, 2023 | 1.21 Bn |
| Mar 31, 2023 | 1.21 Bn |
| Dec 31, 2022 | 1.23 Bn |
| Sep 30, 2022 | 1.17 Bn |
| Jun 30, 2022 | 1.24 Bn |
| Mar 31, 2022 | 1.29 Bn |
| Dec 31, 2021 | 1.42 Bn |
| Sep 30, 2021 | 1.81 Bn |
API Access
Biogen Long-Term Deferred Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-deferred-tax", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();